The Oncology Division incorporates research projects conducted within the Faculty of Medicine, the University Hospital of Maastricht and the MAASTRO Clinic. The aims of this division are on the one hand to gain insights into the basic biology of the cancer process, and on the other to develop new therapeutic strategies based on concepts developed in the laboratory. The rational development of new treatments, therefore, involves the close collaboration between basic scientists and clinical researchers. Three major research lines can be distinguished within the Oncology Division in which several research groups are working.

Research lines and their participants (the leaders of the project groups are in red):

Molecular Oncology

Skin diseases:	Prof.dr. P. Steijlen, dr. M.v Steensel, dr. D. Marcus- Soekarman
Tumour Phenotype:	Prof.dr. F. Ramaekers, dr. B. Schutte
Cancer (cyto)Genetics:	Dr. E. Speel, Prof.dr. B. Kremer, dr. A. Hopman
Cancer Genetics and Epigenetics:	Prof.dr. A. de Bruïne, dr. M.v Engeland
DNA Repair:	Prof.dr. B. Wouters, dr. R. Chiu
EGFR:	Dr. G. Lammering, prof.dr. B. Wouters, dr. J. Theys, prof.dr. P. Lambin

Angiogenesis & Tumour Hypoxia

Hypoxia and Gene Therapy:	Prof.dr. B. Wouters, prof.dr. P. Lambin, dr. M. Koritzinsky, dr. J. Theys
Angiogenesis:	Prof.dr. A. Griffioen, dr. V. Thijssen, dr. S. Tabruyn, dr. J.v Beijnu

Clinical Oncology

Radiation Oncology:	Prof.dr. P. Lambin, prof.dr. B. Wouters, dr. D. de Ruysscher, dr. G. Lammering, dr. A. Dekker, dr. B. Baumert, dr. L. Boersma
Haematology/Cell Therapy:	Dr. G. Bos, dr. W. Germeraad, prof.dr. H. Schouten,
Breast:	Prof.dr. V. Tjan-Heijnen, dr. L. Boersma, dr. K. Flobbe, prof. dr. M. v. Meyenfeldt, prof. dr. J.v. Engelshoven, dr. P. Hupperets, dr. E. Gomez-Garcia
Lung:	Dr. D. de Ruysscher, dr. A. Dingemans
Rectum:	Dr. R. Beets-Tan, dr. G. Lammering, dr. G. Beets

top